Raymond James Trust N.A. reduced its stake in shares of Clorox Company (The) (NYSE:CLX) by 18.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,053 shares of the company’s stock after selling 1,569 shares during the period. Raymond James Trust N.A.’s holdings in Clorox Company (The) were worth $930,000 at the end of the most recent quarter.
Other hedge funds also recently made changes to their positions in the company. American Beacon Advisors Inc. acquired a new position in Clorox Company (The) during the 1st quarter worth $104,000. Parkside Financial Bank & Trust grew its holdings in Clorox Company (The) by 3.8% during the 2nd quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock worth $107,000 after acquiring an additional 29 shares in the last quarter. Valley National Advisers Inc. grew its holdings in Clorox Company (The) by 0.6% during the 1st quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock worth $116,000 after acquiring an additional 5 shares in the last quarter. Sun Life Financial INC grew its holdings in Clorox Company (The) by 10,344.4% during the 2nd quarter. Sun Life Financial INC now owns 940 shares of the company’s stock worth $125,000 after acquiring an additional 931 shares in the last quarter. Finally, Blue Chip Partners Inc. boosted its holdings in shares of Clorox Company (The) by 3.9% in the 2nd quarter. Blue Chip Partners Inc. now owns 941 shares of the company’s stock valued at $125,000 after buying an additional 35 shares during the period. 71.54% of the stock is owned by institutional investors.
In related news, SVP Jon M. Balousek sold 9,223 shares of the business’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total transaction of $1,280,798.01. Following the transaction, the senior vice president now directly owns 20,614 shares of the company’s stock, valued at $2,862,666.18. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Dawn C. Willoughby sold 2,158 shares of the business’s stock in a transaction that occurred on Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total transaction of $297,804.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 41,293 shares of company stock worth $5,560,303. 1.00% of the stock is currently owned by insiders.
COPYRIGHT VIOLATION WARNING: This piece of content was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2017/11/11/clorox-company-the-clx-shares-sold-by-raymond-james-trust-n-a.html.
Shares of Clorox Company (NYSE CLX) traded up $1.37 on Friday, hitting $132.05. 718,800 shares of the stock traded hands, compared to its average volume of 815,927. The firm has a market cap of $16,849.70, a PE ratio of 23.55, a P/E/G ratio of 3.56 and a beta of 0.39. The company has a debt-to-equity ratio of 3.02, a current ratio of 1.10 and a quick ratio of 0.77. Clorox Company has a 12 month low of $111.77 and a 12 month high of $141.76.
Clorox Company (The) (NYSE:CLX) last released its earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.05. The business had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.48 billion. Clorox Company (The) had a net margin of 11.84% and a return on equity of 161.59%. The firm’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same period last year, the firm posted $1.36 earnings per share. equities research analysts forecast that Clorox Company will post 5.58 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, November 13th. Stockholders of record on Wednesday, October 25th will be given a $0.84 dividend. This represents a $3.36 annualized dividend and a dividend yield of 2.54%. The ex-dividend date is Tuesday, October 24th. Clorox Company (The)’s dividend payout ratio (DPR) is currently 61.88%.
Several research analysts have recently commented on the stock. Jefferies Group LLC reaffirmed a “hold” rating and issued a $137.00 price target (up from $136.00) on shares of Clorox Company (The) in a report on Wednesday, August 9th. Consumer Edge raised shares of Clorox Company (The) from a “neutral” rating to an “outperform” rating in a report on Friday. BidaskClub upgraded shares of Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research report on Monday, July 31st. Barclays PLC reiterated an “equal weight” rating and issued a $136.00 price objective (down from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. Finally, BMO Capital Markets set a $150.00 price objective on shares of Clorox Company (The) and gave the company a “buy” rating in a research report on Thursday, August 3rd. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $128.72.
About Clorox Company (The)
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.